- $1.99bn
- $1.92bn
- $693.26m
- 71
- 29
- 51
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 317 | 479 | 892 | 1,120 | 693 |
Cost of Revenue | |||||
Gross Profit | 168 | 213 | 496 | 650 | 386 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 339 | 580 | 832 | 940 | 731 |
Operating Profit | -22.1 | -101 | 60 | 180 | -38.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -32.5 | -115 | 47.9 | 174 | -63.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.9 | -98.6 | 42 | 125 | -73.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -19.9 | -98.6 | 42 | 125 | -73.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.9 | -98.6 | 42 | 125 | -73.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.256 | -1.19 | 0.608 | 1.59 | -0.727 |